1 May 2017

Eva-Leonne Göttgens, PhD candidate at the Radiotherapy & OncoImmunology laboratory, Dept. of Radiation Oncology, was awarded a 3650 EUR travel grant from the René Vogels Stichting.

She received the award in order to perform a work visit to Dr Ester Hammond’s lab at the CRUK-MRC Oxford Insitute for Radiation Oncology in the UK. Her research is focused on unravelling mechanisms of radioresistance in head and neck squamous cell carcinomas. During her time in Oxford, she will investigate the effect of human papillomavirus infections on radioresistance, as well as the involvement of specific DNA damage repair pathways.
  • Want to know more about these subjects? Click on the buttons below for more news.

    Radiation Oncology

Related news items

Villa Joep Research Grant for Radiotherapy & OncoImmunology (ROI) lab

1 December 2021 Renske van den Bijgaart and Gosse Adema from the Radiotherapy & OncoImmunology laboratorium in collaboration with the Prinses Maxima Center received a grant from Villa Joep of 410k Euro. read more

ZonMw funding for PSIDER program

14 July 2021 Michiel Vermeulen, Klaas Mulder and Nael Nadif Kasri receive funding from ZonMw for a collaborative project to develop a stem cell based model to study early human embryogenesis. read more

2.5 million Euros for cancer research into ovarian cancer and immunotherapy

15 April 2021 The Radboudumc receives 2.5 million Euros from the Dutch Cancer Society (KWF) for three studies to ensure oncological progress during COVID-19 period. read more

Exploration meeting Academic Alliance on Oncology

2 December 2019 Within the Academic Alliance, the Maastricht UMC+ and Radboudumc are already working together in several areas. And this is happening in more and more fields. On 27 November researchers from both umc's met during the fourth Exploration meeting, this time with the theme: Oncology. read more

KWF Roadshow 11 November 2019

10 October 2019 In which way(s) can KWF provide optimal support to oncological research and care? How can we maximize impact on our investments? These questions are pivotal in Ambition 2030: the vision that KWF developed in close cooperation with stakeholders in the oncological field. read more